According to Jin10, Hong Kong biotechnology stocks continued to rise, with Mabpharm-B (02181.HK) up 16.28%, WuXi XDC Cayman (02268.HK) rising more than 11%, JW Therapeutics (02126.HK) gaining more than 4%, and WuXi Biologics (02269.HK) also up more than 4%.
Article
STOCKS | Hong Kong Biotechnology Stocks Extend Gains, Mabpharm Surges 16.28%
--・
Disclaimer: Includes third-party opinions. No advice. Binance AI may be used without guarantee. See T&Cs.